1.
Redefining Preeclampsia Using Placenta-Derived Biomarkers
by Staff, Anne Cathrine
Hypertension (Dallas, Tex. 1979), 2013, Vol.61 (5), p.932-942
2.
Pre-eclampsia
by Steegers, Eric AP, Prof
The Lancet (British edition), 2010, Vol.376 (9741), p.631-644
3.
Spiral Artery Remodeling and Trophoblast Invasion in Preeclampsia and Fetal Growth Restriction: Relationship to Clinical Outcome
by LYALL, Fiona
Hypertension (Dallas, Tex. 1979), 2013, Vol.62 (6), p.1046-1054
4.
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
by Blencowe, Hannah, MRCPCH
The Lancet (British edition), 2012, Vol.379 (9832), p.2162-2172
5.
Variations of MicroRNAs in Human Placentas and Plasma From Preeclamptic Pregnancy
by PENG XU
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (6), p.1276-1284
6.
Early Pregnancy Prediction of Preeclampsia in Nulliparous Women, Combining Clinical Risk and Biomarkers: The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study
by KENNY, Louise C
Hypertension (Dallas, Tex. 1979), 2014, Vol.64 (3), p.644-652
7.
Ambient Air Pollution and Pregnancy-Induced Hypertensive Disorders: A Systematic Review and Meta-Analysis
by PEDERSEN, Marie
Hypertension (Dallas, Tex. 1979), 2014, Vol.64 (3), p.494-500
8.
Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
by Akolekar, Ranjit
Fetal diagnosis and therapy, 2013, Vol.33 (1), p.8-15
9.
Gestational trophoblastic disease
by Seckl, Michael J, Prof
The Lancet (British edition), 2010, Vol.376 (9742), p.717-729
10.
Preventing preterm births: analysis of trends and potential reductions with interventions in 39 countries with very high human development index
by Chang, Hannah H, MD
The Lancet (British edition), 2013, Vol.381 (9862), p.223-234
11.
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model
by von Dadelszen, Peter, Dr
The Lancet (British edition), 2011, Vol.377 (9761), p.219-227
12.
New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia
by Verlohren, Stefan
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (2), p.346-352
13.
Mortality risk in preterm and small-for-gestational-age infants in low-income and middle-income countries: a pooled country analysis
by Katz, Joanne, Prof
The Lancet (British edition), 2013, Vol.382 (9890), p.417-425
14.
MicroRNA-376c Impairs Transforming Growth Factor-β and Nodal Signaling to Promote Trophoblast Cell Proliferation and Invasion
by Fu, Guodong
Hypertension (Dallas, Tex. 1979), 2013, Vol.61 (4), p.864-872
15.
Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis
by Brown, Morven Caroline
European journal of epidemiology, 2013, Vol.28 (1), p.1-19
16.
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised control...
by Koopmans, Corine M, Dr
The Lancet (British edition), 2009, Vol.374 (9694), p.979-988
17.
Epidemiology of preeclampsia: impact of obesity
by Jeyabalan, Arun
Nutrition reviews, 2013, Vol.71 (10), p.S18-S25
18.
Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses
by McDonald, Sarah D., MD, MSc
The American heart journal, 2008, Vol.156 (5), p.918-930
19.
Recent Advances in the Understanding of the Pathophysiology of Preeclampsia
by WARRINGTON, Junie P
Hypertension (Dallas, Tex. 1979), 2013, Vol.62 (4), p.666-673
20.
Preeclampsia: Recent Insights
by Roberts, James M
Hypertension (Dallas, Tex. 1979), 2005, Vol.46 (6), p.1243-1249
